Literature DB >> 18481077

Variations in arsenic methylation capacity and oxidative DNA lesions over a 2-year period in a high arsenic-exposed population.

Yuan-yuan Xu1, Yi Wang, Xin Li, Miao He, Peng Xue, Jing-qi Fu, Hui-hui Wang, Gui-fan Sun.   

Abstract

OBJECTIVE: To assess long-term variations in arsenic methylation and oxidative DNA lesions of chronic high arsenic-exposed populations.
METHODS: A follow-up study was conducted in 64 chronic high arsenic-exposed subjects from 2004 to 2006. Urinary arsenic species and 8-hydroxydeoxyguanine were measured.
RESULTS: Percentages of urinary inorganic arsenic, monomethylarsonate and urinary 8-hydroxydeoxyguanine (8-OHdG) level were significantly higher, but the percentage of dimethylarsinate, the primary methylation index (PMI) and secondary methylation index (SMI) was lower in the ninth year of arsenic exposure compared with the seventh year. Substantial differences in relative arsenic methylation capacity were observed between the seventh and ninth year. Percentages of arsenic species, PMI and SMI were significantly correlated between siblings, and between parents and children.
CONCLUSIONS: Arsenic methylation may decrease, but oxidative DNA lesions may increase with the increase of cumulative arsenic exposure level. Both genetic and environmental factors may contribute to variability in arsenic methylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481077     DOI: 10.1007/s00420-008-0329-x

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  37 in total

Review 1.  Methylation of inorganic arsenic in different mammalian species and population groups.

Authors:  M Vahter
Journal:  Sci Prog       Date:  1999       Impact factor: 2.774

2.  Quantitative determination of urinary 8-hydroxydeoxyguanosine (8-OH-dg) by using ELISA.

Authors:  S Saito; H Yamauchi; Y Hasui; J Kurashige; H Ochi; K Yoshida
Journal:  Res Commun Mol Pathol Pharmacol       Date:  2000

3.  Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: induction of chromosomal mutations but not gene mutations.

Authors:  Andrew D Kligerman; Carolyn L Doerr; Alan H Tennant; Karen Harrington-Brock; James W Allen; Ernest Winkfield; Patricia Poorman-Allen; Bijit Kundu; Kunihiro Funasaka; Barbara C Roop; Marc J Mass; David M DeMarini
Journal:  Environ Mol Mutagen       Date:  2003       Impact factor: 3.216

4.  Consumption of folate-related nutrients and metabolism of arsenic in Bangladesh.

Authors:  Julia E Heck; Mary V Gamble; Yu Chen; Joseph H Graziano; Vesna Slavkovich; Faruque Parvez; John A Baron; Geoffrey R Howe; Habibul Ahsan
Journal:  Am J Clin Nutr       Date:  2007-05       Impact factor: 7.045

5.  Variability in human metabolism of arsenic.

Authors:  Christopher A Loffredo; H Vasken Aposhian; Mariano E Cebrian; Hiroshi Yamauchi; Ellen K Silbergeld
Journal:  Environ Res       Date:  2003-06       Impact factor: 6.498

6.  Metabolism and excretion of orally administered dimethylarsinic acid in the hamster.

Authors:  H Yamauchi; Y Yamamura
Journal:  Toxicol Appl Pharmacol       Date:  1984-06-15       Impact factor: 4.219

7.  Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic.

Authors:  C Hopenhayn-Rich; A H Smith; H M Goeden
Journal:  Environ Res       Date:  1993-02       Impact factor: 6.498

Review 8.  Oxidative stress as a possible mode of action for arsenic carcinogenesis.

Authors:  Kirk T Kitchin; Sarfaraz Ahmad
Journal:  Toxicol Lett       Date:  2003-01-31       Impact factor: 4.372

9.  Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China.

Authors:  Guifan Sun; Yuanyuan Xu; Xin Li; Yaping Jin; Bing Li; Xiance Sun
Journal:  Environ Health Perspect       Date:  2007-01-09       Impact factor: 9.031

10.  Genetic polymorphisms influencing arsenic metabolism: evidence from Argentina.

Authors:  Karin Schläwicke Engström; Karin Broberg; Gabriela Concha; Barbro Nermell; Margareta Warholm; Marie Vahter
Journal:  Environ Health Perspect       Date:  2007-01-08       Impact factor: 9.031

View more
  5 in total

1.  Metabolic profile and assessment of occupational arsenic exposure in copper- and steel-smelting workers in China.

Authors:  Shuhua Xi; Quanmei Zheng; Qiang Zhang; Guifan Sun
Journal:  Int Arch Occup Environ Health       Date:  2010-12-04       Impact factor: 3.015

2.  The factors influencing urinary arsenic excretion and metabolism of workers in steel and iron smelting foundry.

Authors:  Xi Shuhua; Sun Qingshan; Wang Fei; Liu Shengnan; Yan Ling; Zhang Lin; Song Yingli; Yan Nan; Sun Guifan
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-12-27       Impact factor: 5.563

Review 3.  Factors Affecting Arsenic Methylation in Arsenic-Exposed Humans: A Systematic Review and Meta-Analysis.

Authors:  Hui Shen; Qiang Niu; Mengchuan Xu; Dongsheng Rui; Shangzhi Xu; Gangling Feng; Yusong Ding; Shugang Li; Mingxia Jing
Journal:  Int J Environ Res Public Health       Date:  2016-02-06       Impact factor: 3.390

4.  Exposure to arsenic in utero is associated with various types of DNA damage and micronuclei in newborns: a birth cohort study.

Authors:  Panida Navasumrit; Krittinee Chaisatra; Jeerawan Promvijit; Varabhorn Parnlob; Somchamai Waraprasit; Chalida Chompoobut; Ta Thi Binh; Doan Ngoc Hai; Nguyen Duy Bao; Nguyen Khac Hai; Kyoung-Woong Kim; Leona D Samson; Joseph H Graziano; Chulabhorn Mahidol; Mathuros Ruchirawat
Journal:  Environ Health       Date:  2019-06-07       Impact factor: 5.984

5.  Arsenic Secondary Methylation Capacity Is Inversely Associated with Arsenic Exposure-Related Muscle Mass Reduction.

Authors:  Md Khalequzzaman Sarker; Selim Reza Tony; Abu Eabrahim Siddique; Md Rezaul Karim; Nazmul Haque; Zohurul Islam; Md Shofikul Islam; Moriom Khatun; Jahidul Islam; Shakhawoat Hossain; Zahangir Alam Saud; Hideki Miyataka; Daigo Sumi; Aaron Barchowsky; Seiichiro Himeno; Khaled Hossain
Journal:  Int J Environ Res Public Health       Date:  2021-09-15       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.